Skip to content

Economic Evaluation Comparing CCT With MMT in Hai Phong City, Vietnam

Economic Evaluation Comparing Center-based Compulsory Drug Treatment With Community-based Methadone Maintenance Treatment in Hai Phong City, Vietnam

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03071315
Enrollment
522
Registered
2017-03-06
Start date
2013-01-20
Completion date
2015-01-30
Last updated
2017-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heroin Dependence

Keywords

Economic evaluation, Heroin dependence, Compulsory treatment, Methadone treatment, Vietnam, East and Southeast Asia, Cost-effectiveness

Brief summary

The study compared the effectiveness and cost-effectiveness of two dominant heroin dependence treatment approaches: center-based compulsory rehabilitation (CCT) and community-based voluntary methadone treatment (MMT) in Hai Phong City, Vietnam. The design was a combined retrospective and prospective, non-randomized cohort over three years (with data at five time-points). The study was conducted between 2012 and 2015, involving 208 CCT participants and 384 MMT participants with heroin dependence.

Detailed description

The study compared the effectiveness and cost-effectiveness of two dominant heroin dependence treatment approaches: center-based compulsory rehabilitation (CCT) and community-based voluntary methadone treatment (MMT) in Hai Phong City, Vietnam. CCT centers are institutions in which people who use drugs are confined for two years. MMT has been internationally recognized as an efficacious treatment for heroin dependence and was introduced in Vietnam in 2008. The design was combined retrospective and prospective, non-randomized cohort over three years (with data at five time-points). The study was conducted between 2012 and 2014, involving 208 CCT participants (of which 80% were followed up) and 384 MMT participants (of which 78% were followed up) with heroin dependence. The five time-points were: baseline, two years after treatment commencement, then three months, six months and 12 months after the initial two years. The study combined primary data and secondary data to assess the effectiveness of the two treatment modalities. The economic component measured the costs of the two treatment modalities to compare cost-effectiveness outcomes. The study had two primary outcomes: self-reported heroin abstinence (confirmed by urine drug screening) and self-reported drug-free days (DFDs). DFDs was reported in two different time-frames. DFDs in the preceding 30 days was used for effectiveness comparison and DFDs over three years was used for the cost-effectiveness comparison. The study has four secondary outcomes: illegal behaviors, overdose, blood-borne virus (BBV) risk behaviors, and monthly drug spending). Mixed effects regression models were used to analyze the effectiveness data and non-parametric bootstrapping methods were used to estimate cost-effectiveness. The time-frame for the cost-effectiveness analysis was three years.

Interventions

OTHERCCT

CCT focuses on behavioral approach, mainly punitive punishment measures.

OTHERMMT

MMT is a combination of pharmaceutical and behavioral intervention.

Sponsors

The Atlantic Philanthropies
CollaboratorOTHER
FHI 360
CollaboratorOTHER
Hanoi Medical University
CollaboratorOTHER
University of Adelaide
CollaboratorOTHER
The University of New South Wales
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

(for CCT Participants): * 18 years of age and older * Heroin dependent * CCT-released participants who were rehabilitated in the CCT centers under the compulsory track. * CCT-released participants who received the recruitment letter sent by CCT centers' staff and who could provide either the recruitment letter or a certificate of CCT treatment completion at the time of first contact with a researcher as a proof that they were newly CCT-released participants. * Consented voluntarily to participate in the study, as assessed and determined by the researcher providing the informed consent documentation.

Exclusion criteria

(for CCT Participants): * Younger than 18 years old * Severe cognitive or mental impairment * Unable to grant consent for this research study * Non-dependent use of heroin. Inclusion Criteria (for MMT Participants): * 18 years of age and older * Heroin dependence, measured by self-reported daily use of heroin during 3 months prior to index treatment, a proxy to measure heroin dependence * Participated in MMT treatment in Hai Phong City from 2008-2009 * Consented voluntarily to participate in this research, as assessed and determined by the researcher providing the informed consent documentation.

Design outcomes

Primary

MeasureTime frameDescription
Heroin abstinencePreceding 3 months and 30 daysFree from heroin use (self-reported), confirmed by urine drug screening on interview day.

Secondary

MeasureTime frameDescription
Drug-free daysPreceding 3 months and 30 daysDays without use of any illicit drugs (self-report)
Drug-use related illegal behaviorsPreceding 3 months and 30 daysDrug-use related illegal behaviors
Drug-use related blood-borne virus (BBV) risk behaviorsPreceding 3 months and 30 daysDrug-use related blood-borne virus (BBV) risk behaviors
Overdose incidentsPreceding 3 months and 30 daysOverdose incidents
Monthly drug spendingPreceding 3 months and 30 daysMonthly drug spending

Countries

Vietnam

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026